Risk factors for rhabdomyolysis with simvastatin and atorvastatin

Drug Saf. 2006;29(12):1191; author reply 1191-2. doi: 10.2165/00002018-200629120-00009.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Atorvastatin
  • Dose-Response Relationship, Drug
  • Heptanoic Acids / administration & dosage
  • Heptanoic Acids / adverse effects*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Pyrroles / administration & dosage
  • Pyrroles / adverse effects*
  • Rhabdomyolysis / chemically induced*
  • Rhabdomyolysis / epidemiology*
  • Risk Factors
  • Simvastatin / administration & dosage
  • Simvastatin / adverse effects*

Substances

  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrroles
  • Atorvastatin
  • Simvastatin